Beta-1A
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2259 publications
Efficacy and tolerability of metformin as an adjuvant therapy in patients with relapse-remitting multiple sclerosis receiving interferon Beta 1a: A randomized pilot trial.
Journal: Journal of neuroimmunology
Published: November 08, 2025
Drug-induced osteoporosis/osteopenia: a pharmacovigilance analysis using the FDA Adverse Event Reporting System database.
Journal: Clinical and experimental rheumatology
Published: September 22, 2025
Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry.
Journal: Journal of child neurology
Published: September 16, 2025
Matching-adjusted indirect comparisons of diroximel fumarate, ocrelizumab and interferon beta-1a for relapsing multiple sclerosis.
Journal: Journal of comparative effectiveness research
Published: September 12, 2025
Beta Interferon 1a and Laquinimod Differentially Affect Coagulation-Related Gene Expression in Multiple Sclerosis Patients: Implications for Clinical Efficacy and Side Effects.
Journal: International journal of molecular sciences
Published: August 31, 2025
Combined intrathecal and intravenous exosome injection efficiency in a multiple sclerosis patient: a case report.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: August 15, 2025
Selected aspects of epidemiology of multiple sclerosis in Poland: a multicenter pilot study.
Journal: Neurologia i neurochirurgia polska
Published: July 21, 2025
Bridging pharmacovigilance and genetic insight: investigating drugs and indications for breast cancer risk in women with autoimmune diseases.
Journal: Journal of translational medicine
Published: July 17, 2025
Outcomes of older patients with multiple sclerosis treated with interferon beta-1a or peginterferon beta-1a in MS PATHS.
Journal: Neurodegenerative disease management
Published: July 15, 2025
Therapeutic evaluation of immunomodulators and immunosuppressants in progressive multiple sclerosis: summary of a Cochrane systematic review.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: June 15, 2025
A multicentre, prospective, randomized, open-label pragmatic trial to compare the effectiveness and safety of interferon beta-1a and glatiramer-acetate in paediatric patients affected by Multiple Sclerosis.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: June 11, 2025
What Is the Evidence on Immunomodulators and Immunosuppressants for Progressive Multiple Sclerosis? - A Cochrane Review Summary with Commentary.
Journal: NeuroRehabilitation
Published: June 09, 2025
Last Updated: 02/24/2026